Cardiac energy metabolism in heart failure

GD Lopaschuk, QG Karwi, R Tian, AR Wende… - Circulation …, 2021 - Am Heart Assoc
Alterations in cardiac energy metabolism contribute to the severity of heart failure. However,
the energy metabolic changes that occur in heart failure are complex and are dependent not …

Mechanisms of physiological and pathological cardiac hypertrophy

M Nakamura, J Sadoshima - Nature Reviews Cardiology, 2018 - nature.com
Cardiomyocytes exit the cell cycle and become terminally differentiated soon after birth.
Therefore, in the adult heart, instead of an increase in cardiomyocyte number, individual …

Ceramides and other sphingolipids as drivers of cardiovascular disease

RH Choi, SM Tatum, JD Symons… - Nature Reviews …, 2021 - nature.com
Increases in calorie consumption and sedentary lifestyles are fuelling a global pandemic of
cardiometabolic diseases, including coronary artery disease, diabetes mellitus …

Diabesity: the combined burden of obesity and diabetes on heart disease and the role of imaging

ACT Ng, V Delgado, BA Borlaug, JJ Bax - Nature Reviews Cardiology, 2021 - nature.com
Diabesity is a term used to describe the combined adverse health effects of obesity and
diabetes mellitus. The worldwide dual epidemic of obesity and type 2 diabetes is an …

Metabolic remodelling in heart failure

E Bertero, C Maack - Nature Reviews Cardiology, 2018 - nature.com
The heart consumes large amounts of energy in the form of ATP that is continuously
replenished by oxidative phosphorylation in mitochondria and, to a lesser extent, by …

Sphingolipids in metabolic disease: The good, the bad, and the unknown

CD Green, M Maceyka, LA Cowart, S Spiegel - Cell metabolism, 2021 - cell.com
The bioactive sphingolipid metabolites ceramide and sphingosine-1-phosphate (S1P) are a
recent addition to the lipids accumulated in obesity and have emerged as important …

Altered cardiac energetics and mitochondrial dysfunction in hypertrophic cardiomyopathy

S Ranjbarvaziri, KB Kooiker, M Ellenberger, G Fajardo… - Circulation, 2021 - Am Heart Assoc
Background: Hypertrophic cardiomyopathy (HCM) is a complex disease partly explained by
the effects of individual gene variants on sarcomeric protein biomechanics. At the cellular …

Ceramides in metabolism: key lipotoxic players

B Chaurasia, SA Summers - Annual review of physiology, 2021 - annualreviews.org
The global prevalence of metabolic diseases such as type 2 diabetes mellitus,
steatohepatitis, myocardial infarction, and stroke has increased dramatically over the past …

Evidence for intramyocardial disruption of lipid metabolism and increased myocardial ketone utilization in advanced human heart failure

KC Bedi Jr, NW Snyder, J Brandimarto, M Aziz… - Circulation, 2016 - Am Heart Assoc
Background—The failing human heart is characterized by metabolic abnormalities, but
these defects remains incompletely understood. In animal models of heart failure there is a …

Lipid droplets in cancer: guardians of fat in a stressful world

T Petan, E Jarc, M Jusović - Molecules, 2018 - mdpi.com
Cancer cells possess remarkable abilities to adapt to adverse environmental conditions.
Their survival during severe nutrient and oxidative stress depends on their capacity to …